Hydrogen is the smallest molecule there is, and the reasonable assumption was that it would wash through the body without stopping anywhere in particular. Then a research team went looking for it in the liver and found it sitting there. Kamimura and colleagues, publishing in Obesity in 2011, reported that hepatic glycogen — the carbohydrate the liver banks between meals — accumulated hydrogen after oral administration of hydrogen water in mice. This was animal research, not a human trial, and we will keep saying so. But the finding redirected an entire branch of the field.
That is the reason the metabolic literature on hydrogen water reads the way it does. The liver is not an incidental organ in this story. It is the organ where the gas appeared to linger, and it is the organ that sets the numbers on almost every panel a person uses to think about metabolic health — total cholesterol, triglycerides, fasting blood glucose, liver enzymes, liver fat itself. Researchers followed the hydrogen to the liver, and the human trials followed the researchers.
Why the Liver Keeps Showing Up in Hydrogen Research
Most emerging wellness compounds have one suggestive study and a lot of enthusiasm. The hydrogen water literature on metabolic health is unusually dense by comparison. There is an eight-week randomized, double-blind, placebo-controlled crossover trial in patients with type 2 diabetes and impaired glucose tolerance. There is a ten-week trial that tested HDL function four separate ways. There is a twenty-four-week randomized controlled trial in metabolic syndrome. There is a twenty-eight-day pilot trial that measured liver fat directly with MRI rather than inferring it from a blood marker. And as of 2024, there is a PRISMA-guided systematic review with meta-analysis pooling eight randomized trials.
Five separate research groups, five separate designs, one organ system. That kind of convergence is rare in a young field.
What follows is a walk through those studies in the order they were published, with the findings stated the way the researchers stated them. Nothing here is a claim about what hydrogen-rich water will do for any individual reader. It is a report on what a specific set of trials measured, in specific groups of patients, over specific windows of time.
Metabolic Health, Oxidative Stress, and the Organ in the Middle
What "Metabolic Health" Actually Covers
Metabolic health is a bundle, not a single reading. Clinicians generally look at fasting blood glucose, the lipid panel (total cholesterol, LDL, HDL, triglycerides), blood pressure, and waist circumference. When enough of those markers drift together, the cluster gets the label metabolic syndrome. The liver is the common denominator underneath most of them — it manufactures cholesterol, packages and exports triglycerides, stores and releases glucose, and handles the traffic between meals and fasting.
Which is why a research finding about hydrogen and hepatic glycogen was not a curiosity. It was a map reference. If the gas concentrates in the organ that governs lipid and glucose handling, then lipid and glucose endpoints are the obvious place to look next — and that is precisely where the human trials went.
Where Oxidative Stress Enters the Picture
Oxidative stress is the term researchers use for the imbalance between reactive oxygen species and the body's capacity to manage them. Not all reactive oxygen species are villains; several carry signaling duties the body depends on. The hydroxyl radical is the one that draws the most attention in the literature, because it reacts with essentially any biological molecule it encounters and there is no dedicated enzyme to detoxify it.
Ohsawa and colleagues put that specific radical at the center of the hydrogen story in 2007, and every metabolic trial that followed inherited the framing. The trials did not just measure cholesterol and glucose levels. They measured redox markers alongside them — urinary 8-isoprostanes, superoxide dismutase activity, thiobarbituric acid reactive substances — because the hypothesis under test was always about oxidative stress as the mechanism connecting the two.
The Selectivity Finding Underneath All of It
The 2007 paper in Nature Medicine is the one everything else cites. Ohsawa and colleagues reported that molecular hydrogen appeared to selectively reduce the hydroxyl radical, described in their work as the most cytotoxic of the reactive oxygen species, while not reacting with other reactive oxygen species that possess physiological roles. Selective, not indiscriminate.
That distinction is the whole reason the field kept going. A broad antioxidant knocks down useful signaling along with the damage. The selectivity the researchers described suggested a different profile — one where the aggressive radical is addressed and the signaling molecules the body relies on are left to do their jobs. Whether that mechanism fully explains the human results is still an active research question, and the trials below were designed by people who found the question worth twenty-four weeks of their time.
Hydrogen Nutrition as a Research Category
Ohta's two review articles — the 2014 overview in Pharmacology & Therapeutics and the 2015 methods chapter in Methods in Enzymology — are the standard entry points for anyone tracing how this became a research category rather than a single paper. They document how hydrogen medicine developed from the initial selectivity report into a program spanning dozens of models and delivery routes, and they cover the practical side of the work: how hydrogen is dissolved, how it is measured, how the dosing in published research was arrived at. Some authors now group the drinking-water arm of that work under the heading of hydrogen nutrition, which is a useful shorthand for what the metabolic trials are actually studying.
The Animal Study That Sent Researchers to the Liver
Hepatic Glycogen Held the Hydrogen
Kamimura and colleagues published their work in Obesity in 2011. This is an animal study — db/db mice and high-fat-diet wild-type mice, not human patients — and the distinction matters enough to state twice. What the researchers reported was that hepatic glycogen accumulated hydrogen after oral administration of hydrogen water. The gas did not simply diffuse away on the first pass.
Reading that result alongside the human trials is the exercise this article is built around. The animal work supplies a mechanism-shaped hypothesis about why the liver might be a responsive site. The human work supplies the endpoints that a person can actually see on a lab report.
Fatty Liver, FGF21, and Energy Metabolism in Mice
In the same set of experiments, the researchers reported that drinking hydrogen water alleviated fatty liver in the db/db mice and in the wild-type mice fed a high-fat diet. They also reported enhanced hepatic expression of FGF21, a liver-derived hormone involved in fatty acid and glucose handling, and stimulation of energy metabolism as measured by oxygen consumption.
Mice are not people. The value of the study is directional — it told the field where to point the human trials, and the human trials that followed did find measurable movement in liver-related endpoints. That sequence, animal signal followed by human measurement, is how a research program is supposed to unfold.
How Metabolic Health Gets Measured in These Trials
The Lipid Panel — Total Cholesterol, LDL, and apoB Levels
Every trial in this cluster reports lipids, and the details are where the interest lives. Total cholesterol and LDL cholesterol are the familiar numbers. Underneath them sit finer measures: modified (oxidized) LDL, small dense LDL particles, and apoB levels — apolipoprotein B being the structural protein carried by each atherogenic particle, which makes it a count of particles rather than a measure of the cholesterol inside them. Two of the trials below went past the standard panel into that finer territory.
Blood Glucose, Glucose Levels, and HbA1c
On the glucose side, the trials report fasting blood glucose, oral glucose tolerance testing, and HbA1c — the glycated hemoglobin figure that reflects average glucose levels across roughly the previous three months rather than the previous twelve hours. Fasting glucose is a snapshot. HbA1c is the trailing average. A trial that reports movement in both is describing something more durable than a single morning's reading, which is why the twenty-four-week study is the one that carries the most weight on this particular endpoint.
Kajiyama 2008: Lipids and Glucose in a Crossover Trial
How the Crossover Trial Was Built
Kajiyama and colleagues published in Nutrition Research in 2008 — a randomized, double-blind, placebo-controlled crossover study in thirty patients with type 2 diabetes and six with impaired glucose tolerance. Participants drank 900 mL per day of hydrogen-rich water for eight weeks. Crossover means every participant served as their own control, which is a strong design for a small sample.
What Changed in the Glucose Patients
The researchers reported that modified LDL cholesterol decreased by 15.5% (P<.01), small dense LDL by 5.7% (P<.05), and urinary 8-isoprostanes — a marker of oxidative stress — by 6.6% (P<.05) during the hydrogen-rich water period. They also observed trends toward decreased oxidized LDL and free fatty acids, and toward increased adiponectin and extracellular superoxide dismutase.
The line that gets quoted most often concerns the smaller subgroup. Among the six impaired glucose patients, the researchers reported that oral glucose tolerance test results normalized in four. Four out of six. That is a small number and the authors treated it as such.
Song 2013: Total Cholesterol, apoB Levels, and HDL Function
Four Independent Tests of HDL Function
Song and colleagues, writing in the Journal of Lipid Research in 2013, studied twenty patients with potential metabolic syndrome who drank 0.9 to 1.0 litres of hydrogen-rich water daily for ten weeks. The headline numbers were decreases in serum total cholesterol and LDL cholesterol, plus what the authors described as a marked decrease in apoB100 and apoE.
The more unusual part of the paper is what they did with HDL. Rather than reporting HDL as a concentration and stopping there, the researchers assessed HDL functionality on four independent measures and reported improvement across all of them: protection against LDL oxidation, inhibition of TNF-α-induced monocyte adhesion to endothelial cells, stimulation of cholesterol efflux from macrophage foam cells, and protection of endothelial cells from TNF-α-induced apoptosis. They also reported increased superoxide dismutase and decreased thiobarbituric acid reactive substances.
Anti-Apoptotic Effects in the Endothelial Assay
That last assay is worth pausing on. Protection of endothelial cells from cytokine-induced cell death is what the anti-apoptotic effects language in this literature refers to — and endothelial health is measurable in living people through vascular function testing, a subject we cover separately in our piece on flow-mediated dilation as a cardiovascular health marker. A trial that reports movement in both the lipid particle count and the functional behavior of the particles is describing two different kinds of evidence at once, and the fact that the group built four separate functional assays rather than settling for one number is the sort of methodological care that makes a small trial punch above its sample size.
Korovljev 2019: Liver Fat, Measured by MRI
Twenty-Eight Days, One Litre a Day
Korovljev, Stajer, Ostojic, LeBaron and Ostojic published a randomized controlled pilot trial in Clinics and Research in Hepatology and Gastroenterology in 2019. Twelve overweight outpatients with non-alcoholic fatty liver disease, double-blind, placebo-controlled, crossover design, one litre of hydrogen-rich water per day for twenty-eight days. A pilot trial with twelve participants, and the authors labeled it exactly that.
The load-bearing result came from imaging rather than bloodwork. Using dual-echo MRI, the researchers reported significantly reduced liver fat accumulation compared with placebo (P<0.05). Serum AST dropped 10.0% as well, though the 95% confidence interval for that change ran from −23.2 to 3.4, which makes it a trend rather than a demonstrated difference. No significant differences in weight or body composition were reported.
Direct imaging of the organ is the reason this study matters more than its sample size suggests. Most nutritional trials infer liver status from enzymes in the blood. This one photographed the fat. Twenty-eight days, one measurable change in the organ where the animal work said to look.
LeBaron 2020: Twenty-Four Weeks in Metabolic Syndrome
Inflammation and Redox Homeostasis
The longest trial in the cluster ran twenty-four weeks. LeBaron, Singh, Fatima and colleagues, publishing in Diabetes, Metabolic Syndrome and Obesity in 2020, randomized sixty subjects — thirty men and thirty women with metabolic syndrome — to high-concentration hydrogen-rich water delivering more than 5.5 mmol of hydrogen per day, or to placebo, in a double-blinded design.
Against placebo, the researchers reported significantly reduced blood cholesterol and glucose, attenuated HbA1c, and improved biomarkers of inflammation and redox homeostasis (P<0.05). Six months of daily drinking HRW, sixty participants, blinded throughout, with movement reported on the lipid, glucose and inflammatory axes simultaneously — that combination of duration, sample size and endpoint breadth is what makes this the anchor study of the group,.
Jamialahmadi 2024: Eight Randomized Trials, Pooled
Duration Appeared to Matter
Jamialahmadi, Khalili-Tanha, Rezaei-Tavirani and Nazari published a PRISMA-guided systematic review and meta-analysis in the International Journal of Endocrinology and Metabolism in 2024. Eight randomized controlled trials, 357 patients in total, literature searched through January 2024. Every included study was rated at no or low risk of bias on the Jadad scale — which, for a nutritional field this young, is a genuinely strong quality profile.
The pooled result was a modest lipid-lowering effect, with triglycerides showing the clearest decrease (95% CI −0.47 to −0.07). Modest is the honest word, and it is the word this article will keep using.
The meta-regression is the part worth remembering. The authors reported a positive association between outcome and intervention duration — longer trials, larger effect. Read alongside the twenty-four-week trial that produced the broadest set of findings in the whole cluster, that association points somewhere specific: consistency over time appears to be doing work that a short trial cannot capture.
The Gut, the Microbiota, and What Comes Next
Here is a fact that surprises most people the first time they hear it. Your gut already makes hydrogen. The microbiota fermenting non-digestible carbohydrates in the colon produce hydrogen gas continuously, a point Ohta's reviews return to when explaining why the body has a long evolutionary acquaintance with this molecule and why the safety picture in the published trials has been as clean as it has.
That endogenous production is one of the more interesting open threads in the field. Diet shapes which microbiota flourish, which shapes the metabolites and gases they generate, and the gas in question here happens to be the same one the trials above delivered in a glass. Researchers exploring the connection between hydrogen nutrition and the gut are working on a question the metabolic trials did not set out to answer, and it is the kind of thread that tends to produce the next generation of studies.
For now the drinking-water evidence stands on its own — six studies deep on the metabolic side alone, with the pooled analysis published in 2024 and the trial durations trending longer.
What HRW Intake Looked Like Across the Published Trials
The intake figures in these studies are strikingly ordinary. Kajiyama used 900 mL per day. Song used 0.9 to 1.0 litres per day. Korovljev used one litre per day. LeBaron used a high-concentration preparation delivering more than 5.5 mmol of hydrogen daily. Nobody was drinking exotic quantities; they were drinking about as much water as a person drinks anyway, with hydrogen dissolved in it.
What the Stack Adds Up To
The metabolic research on hydrogen-rich water is not a single dramatic result. It is a stack — an animal study that found the gas in the liver, a crossover trial that reported changes in lipid particles and normalized glucose tolerance in four of six impaired-glucose patients, a ten-week trial that tested HDL function four different ways and reported improvement on all four, an MRI pilot that reported less liver fat, a twenty-four-week randomized controlled trial that reported movement in cholesterol, glucose and inflammatory markers together, and a 2024 meta-analysis that pooled eight randomized trials and found modest effects. Modest effects, measured in small samples, from independent groups.
Further Reading
- Ohta S. Molecular hydrogen as a preventive and therapeutic medical gas. A wide-ranging review that traces how a single 2007 observation grew into a research program spanning dozens of models and delivery routes — the best single overview for a reader who wants the whole map. PubMed 24769081
- Ohta S. Molecular hydrogen as a novel antioxidant. A methods-oriented review covering the practical side: how hydrogen gets dissolved, how it gets measured, and how researchers arrived at the amounts used in published studies. PubMed 25747486
- Jamialahmadi H, et al. Hydrogen-rich water and blood lipid profiles in metabolic disorders. The systematic review and meta-analysis that pooled eight randomized trials and 357 patients; triglycerides showed the clearest movement, and longer studies showed larger effects. PMC11742746
- Ohsawa I, et al. Hydrogen acts as a therapeutic antioxidant. The original paper behind the selectivity idea — hydrogen reacted with the hydroxyl radical but left reactive oxygen species with signaling duties alone. PubMed 17486089
- Song G, et al. Hydrogen-rich water and HDL function in potential metabolic syndrome. Worth reading for the methodology alone: four separate functional assays of HDL rather than a single concentration reading. PMC3679390
- Korovljev D, et al. Hydrogen-rich water and liver fat in non-alcoholic fatty liver disease. A small pilot that skipped the blood-marker proxy and imaged the liver directly with dual-echo MRI across twenty-eight days. PubMed 30982748
- LeBaron TW, et al. Twenty-four weeks of high-concentration hydrogen-rich water in metabolic syndrome. The longest trial in this group, and the one that reported movement on lipids, glucose and inflammatory markers at the same time. PMC7102907
References
[1] Ohsawa I, Ishikawa M, Takahashi K, et al. "Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals." Nature Medicine. 2007;13(6):688-94. PMID: 17486089; DOI: 10.1038/nm1577
[2] Kajiyama S, Hasegawa G, Asano M, et al. "Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance." Nutrition Research. 2008;28(3):137-43. PMID: 19083400; DOI: 10.1016/j.nutres.2008.01.008
[3] Kamimura N, Nishimaki K, Ohsawa I, Ohta S. "Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice." Obesity. 2011;19(7):1396-403. PMID: 21293445; DOI: 10.1038/oby.2011.6
[4] Song G, Li M, Sang H, et al. "Hydrogen-rich water decreases serum LDL-cholesterol levels and improves HDL function in patients with potential metabolic syndrome." Journal of Lipid Research. 2013;54(7):1884-93. PMID: 23610159; PMC3679390; DOI: 10.1194/jlr.M036640
[5] Korovljev D, Stajer V, Ostojic J, LeBaron TW, Ostojic SM. "Hydrogen-rich water reduces liver fat accumulation and improves liver enzyme profiles in patients with non-alcoholic fatty liver disease: a randomized controlled pilot trial." Clinics and Research in Hepatology and Gastroenterology. 2019;43(6):688-693. PMID: 30982748; DOI: 10.1016/j.clinre.2019.03.008
[6] LeBaron TW, Singh RB, Fatima G, et al. "The effects of 24-week, high-concentration hydrogen-rich water on body composition, blood lipid profiles and inflammation biomarkers in men and women with metabolic syndrome: a randomized controlled trial." Diabetes, Metabolic Syndrome and Obesity. 2020;13:889-896. PMID: 32273740; PMC7102907; DOI: 10.2147/DMSO.S240122
[7] Jamialahmadi H, Khalili-Tanha G, Rezaei-Tavirani M, Nazari E. "The effects of hydrogen-rich water on blood lipid profiles in metabolic disorders clinical trials: a systematic review and meta-analysis." International Journal of Endocrinology and Metabolism. 2024;22(3):e148600. PMID: 39839806; PMC11742746; DOI: 10.5812/ijem-148600
[8] Ohta S. "Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine." Pharmacology & Therapeutics. 2014;144(1):1-11. PMID: 24769081; DOI: 10.1016/j.pharmthera.2014.04.006
[9] Ohta S. "Molecular hydrogen as a novel antioxidant: overview of the advantages of hydrogen for medical applications." Methods in Enzymology. 2015;555:289-317. PMID: 25747486; DOI: 10.1016/bs.mie.2014.11.038
Nothing in this article is intended to diagnose, treat, cure, or prevent any disease. All information on this site is provided for educational and general wellness purposes only and should not be considered medical advice. Always consult a qualified healthcare provider before beginning any new wellness practice, especially if you have a medical condition, are pregnant or nursing, or take prescription medications.